Cargando…

Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins

Detalles Bibliográficos
Autores principales:	Pommier, Yves, Cushman, Mark, Doroshow, James H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324668/ https://www.ncbi.nlm.nih.gov/pubmed/30647868 http://dx.doi.org/10.18632/oncotarget.26466

Ejemplares similares

Design, Synthesis, and Biological Evaluation of O-2-Modified Indenoisoquinolines as Dual Topoisomerase I–Tyrosyl-DNA Phosphodiesterase I Inhibitors
por: Lv, Peng-Cheng, et al.
Publicado: (2014)

Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome
por: Lee, Hyeong-Min, et al.
Publicado: (2018)

Binding of an Indenoisoquinoline to the Topoisomerase-DNA Complex Induces Reduction of Linker Mobility and Strengthening of Protein-DNA Interaction
por: Mancini, Giordano, et al.
Publicado: (2012)

Synthesis and Biological Evaluation of New Carbohydrate-Substituted Indenoisoquinoline Topoisomerase I Inhibitors and Improved Syntheses of the Experimental Anticancer Agents Indotecan (LMP400) and Indimitecan (LMP776)
por: Beck, Daniel E., et al.
Publicado: (2014)

Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor
por: Molinaro, Caroline, et al.
Publicado: (2023)

Solvent Dependency of the UV-Vis Spectrum of Indenoisoquinolines: Role of Keto-Oxygens as Polarity Interaction Probes
por: Coletta, Andrea, et al.
Publicado: (2013)

A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas
por: Molinaro, Caroline, et al.
Publicado: (2022)

Optimization of the Lactam Side Chain of 7-Azaindenoisoquinoline Topoisomerase I Inhibitors and Mechanism of Action Studies in Cancer Cells
por: Kiselev, Evgeny, et al.
Publicado: (2014)

New Topoisomerase I mutations are associated with resistance to camptothecin
por: Gongora, Céline, et al.
Publicado: (2011)

Mechanism of action of non-camptothecin inhibitor Genz-644282 in topoisomerase I inhibition
por: Nishida, Masahiro, et al.
Publicado: (2022)

Quantitative Structure-Activity Relationship Studies on Indenoisoquinoline Topoisomerase I Inhibitors as Anticancer Agents in Human Renal Cell Carcinoma Cell Line SN12C
por: Zhi, Yi, et al.
Publicado: (2012)

Differential induction of Leishmania donovani bi-subunit topoisomerase I–DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I
por: Das, Benu Brata, et al.
Publicado: (2006)

Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer
por: Lee, Yu-Chieh, et al.
Publicado: (2015)

Sensitization of Cancer Cells to Radiation and Topoisomerase I Inhibitor Camptothecin Using Inhibitors of PARP and Other Signaling Molecules
por: Matsuno, Yusuke, et al.
Publicado: (2018)

Characterization of DNA Topoisomerase-1 in Spodoptera exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin
por: Zhang, Lan, et al.
Publicado: (2013)

Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity
Publicado: (1996)

Effects of camptothecin derivatives and topoisomerase dual inhibitors on Trypanosoma cruzi growth and ultrastructure
por: Lacombe, Otto Kischlat, et al.
Publicado: (2014)

The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis
por: Czuwara-Ladykowska, Joanna, et al.
Publicado: (2001)

Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study
por: Siu, Fung-Ming, et al.
Publicado: (2013)

Evaluation of Two Models for Human Topoisomerase I Interaction with dsDNA and Camptothecin Derivatives
por: Laco, Gary S.
Publicado: (2011)

Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
por: Ando, Koji, et al.
Publicado: (2017)

The benzylisoquinoline alkaloids, berberine and coptisine, act against camptothecin-resistant topoisomerase I mutants
por: Inoue, Naomi, et al.
Publicado: (2021)

DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1α gene locus
por: Baranello, Laura, et al.
Publicado: (2010)

Poly(ADP-ribose) polymerase and XPF–ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells
por: Zhang, Yong-Wei, et al.
Publicado: (2011)

CK2-Mediated Hyperphosphorylation of Topoisomerase I Targets Serine 506, Enhances Topoisomerase I–DNA Binding, and Increases Cellular Camptothecin Sensitivity
por: Bandyopadhyay, Keya, et al.
Publicado: (2012)

Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal
por: Frøhlich, Rikke From, et al.
Publicado: (2007)

Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study
por: Tesauro, Cinzia, et al.
Publicado: (2019)

The modulation of topoisomerase I-mediated DNA cleavage and the induction of DNA–topoisomerase I crosslinks by crotonaldehyde-derived DNA adducts
por: Dexheimer, Thomas S., et al.
Publicado: (2008)

Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents
por: Drwal, Malgorzata N., et al.
Publicado: (2011)

Three missense mutations of DNA topoisomerase I in highly camptothecin-resistant colon cancer cell sublines
por: ARAKAWA, YASUHIRO, et al.
Publicado: (2013)

Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues
por: Pfister, Thomas D., et al.
Publicado: (2012)

Topoisomerase gets around
por: Dove, Alan W.
Publicado: (2002)

Functions of the CSB Protein at Topoisomerase 2 Inhibitors-Induced DNA Lesions
por: Busatto, Franciele Faccio, et al.
Publicado: (2021)

The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant
por: Fiorani, Paola, et al.
Publicado: (2006)

Nitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor Cells
por: Sharma, Nilesh K., et al.
Publicado: (2015)

PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin
por: Mouly, Laetitia, et al.
Publicado: (2018)

Role of the protein in the DNA sequence specificity of the cleavage site stabilized by the camptothecin topoisomerase IB inhibitor: a metadynamics study
por: Coletta, Andrea, et al.
Publicado: (2013)

Replacement of the Human Topoisomerase Linker Domain with the Plasmodial Counterpart Renders the Enzyme Camptothecin Resistant
por: Arnò, Barbara, et al.
Publicado: (2013)

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer
por: Shamanna, Raghavendra A., et al.
Publicado: (2016)

Novel bivalent securinine mimetics as topoisomerase I inhibitors
por: Hou, Wen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k0uth3kg5omiki470u6h44v29k